To explore the potential association between PRDX1 expression and sensitivity to ICI therapy in CRC patients, we further reanalyzed scRNA‐seq dataset (GSE166555) according to the MSS and MSI‐H immune subtypes. The gene discussed is PRDX1; the disease is colorectal carcinoma.